Keytruda for Non Small Cell Lung Cancer User Reviews (Page 5)
Reviews for Keytruda
- Nic...
- Taken for less than 1 month
- December 7, 2018
"It gave me extreme diarrhea and terrible stomach pain. If I could go back and not take this medication, I would. I discontinued it after 30 days."
- Anonymous
- Taken for less than 1 month
- May 8, 2018
"Well, my mom took one dose. She had been tired, not much of an appetite. Have hope this will lengthen her life. We will see her when she has her scan done, hopefully, it reduces."
Frequently asked questions
- What is the success rate of Keytruda?
- How long does it take for Keytruda to work?
- What are Monoclonal Antibodies and how do they work?
- Pembrolizumab vs. nivolumab: How do they compare?
- Joh...
- Taken for 6 months to 1 year
- August 25, 2024
"Very good so far. Almost a year, and only now a loose stool. Not had too bad a time, some sleepiness, dizziness, fatigue."
- RBs...
- Taken for 1 to 6 months
- March 20, 2024
"I'm having hungry feelings but don't want anything. I think I do, but I don't. I have no pain. Food is either too salty or too sweet."
- Kat...
- Taken for 6 months to 1 year
- September 5, 2024
"Skin very, very dry. Sores in mouth (lasted only a short time). Neuropathy in feet and fingertips. Constipation/diarrhea. The neuropathy is the only one I can’t stand."
- EAR...
- Taken for 2 to 5 years
- July 10, 2025
"Using Keytruda for over 2.5 years with very positive results."
- Deb...
- Taken for 1 to 2 years
- April 13, 2025
"I've been taking Keytruda for over a year every three weeks. It is very easy for me, and the only side effect is extreme tiredness. I have Stage 4 adenocarcinoma lung cancer."
See also:
More about Keytruda (pembrolizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (262)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
"Excellent 5.5 years, tested 80% positive PDL... Original diagnosis Nov 2017, Stage 4 metastatic NSCLC. Stopped treatment Oct 2022... Regular scans show no active disease."